Belmont, MA, United States of America

Thorold W Theunissen

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Thorold W Theunissen: Innovator in Stem Cell Research

Introduction

Thorold W Theunissen is a prominent inventor based in Belmont, MA (US). He has made significant contributions to the field of stem cell research, holding 2 patents that focus on enhancing methods for inducing and maintaining naive human pluripotent stem cells.

Latest Patents

His latest patents include "Enhanced methods for inducing and maintaining naive human pluripotent stem cells," which provides methods and compositions for inducing, maintaining, and/or passaging naïve pluripotent stem cells. Notably, these methods are performed in the absence of MEK inhibition, which has been shown to result in genomic instability of naïve pluripotent stem cells. Another significant patent is "Uses of kinase inhibitors for inducing and maintaining pluripotency," which details compounds that include various inhibitors useful in changing the pluripotency state of a vertebrate cell to a more naïve state.

Career Highlights

Throughout his career, Thorold has worked with esteemed institutions such as the Whitehead Institute for Biomedical Research and Dana-Farber Cancer Institute Inc. His work has been pivotal in advancing the understanding of pluripotent stem cells and their applications in regenerative medicine.

Collaborations

Thorold has collaborated with notable scientists in the field, including Rudolf Jaenisch and Nathanael Schiander Gray. These collaborations have further enriched his research and contributed to the scientific community's knowledge of stem cell biology.

Conclusion

Thorold W Theunissen's innovative work in stem cell research has led to significant advancements in the field. His patents and collaborations reflect his commitment to enhancing our understanding of pluripotency and its applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…